Breast cancer is the most-researched disease, yet only 14% of trials reach optimal enrollment, highlighting a significant gap in clinical trial participation. COVID-19 has increased trial attrition ...

The FDA has approved revumenib (Revuforj; Syndax Pharmaceuticals) for patients aged 1 year and older with relapsed or ...

Liver Awareness Month, observed each October, increases public understanding of the causes, symptoms, and outcomes of liver disease and highlights steps that can be taken at both the individual and ...

Elinzanetant provides a hormone-free treatment option for vasomotor symptoms by targeting the brain's thermoregulatory center ...

Menopause comes with more symptoms than just hot flashes—many women experience major shifts in body composition that can influence long-term health. These changes are different from those seen with ...

Craig See, MD, a cornea specialist for the Cole Eye Institute at Cleveland Clinic, emphasized that cornea injuries are ...

Treating vasomotor symptoms, sleep disturbance, and mood disorders can remove barriers to weight loss for women during menopause, experts say.

The FDA rounded out the month with the approval of remibrutinib (Rhapside; Novartis), a highly selective Bruton tyrosine kinase inhibitor (BTKi), for patients with chronic spontaneous urticaria (CSU) ...

Researchers have found that using mobile-app–based surveys and photography to remotely track and assess atopic dermatitis (AD ...

Consolidative radiotherapy (RT) can improve outcomes in patients with diffuse large B-cell lymphoma (DLBCL), according to a ...

Belantamab mafodotin provides a community-friendly BCMA-directed therapy option for relapsed/refractory myeloma, says Hearn ...

Belantamab mafodotin, a BCMA-targeting ADC, is approved for relapsed/refractory multiple myeloma after two prior therapies, ...